Paula Witt-Enderby | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Paula Witt-Enderby


An Early Development Budget Impact Model for the Use of Melatonin in the Treatment and Prevention of Osteoporosi

In the U.S., there are approximately 9 million adults with osteoporosis (OP) and an additional 43 million at-risk. By 2030, this number is expected to increase to 68 million adults. The economic impact is estimated to be $23 billion by 2025. Current drug therapies either decrease bone resorption (e.g., bisphosphonates) or stimulate bone formation (... Read More»

Corry D Bondi, Rahul Khairnar, Khalid M. Kamal and Paula Witt-Enderby

Research Article: Clin Pharmacol Biopharm 2015, 4:132

DOI: 10.4172/2167-065X.1000132

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF